Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Renal cell carcinoma | R-HSA-9794523 | map05211 | diethylcarbamazine | 708857 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | diethylcarbamazine | 708857 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | diethylcarbamazine | 708857 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | diethylcarbamazine | 708857 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | diethylcarbamazine | 708857 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | diethylcarbamazine | 708857 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | diethylcarbamazine | 708857 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | diethylcarbamazine | 708857 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | diethylcarbamazine | 708857 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cyclopentolate | 2905 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | cyclopentolate | 2905 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | cyclopentolate | 2905 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cyclopentolate | 2905 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cyclopentolate | 2905 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | cyclopentolate | 2905 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | cyclopentolate | 2905 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | alfaxalone | 1892 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | alfaxalone | 1892 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | alfaxalone | 1892 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | alfaxalone | 1892 | drug-path |